• ქართული
  • English
  • Merck profit beats on Keytruda strength, raises full-year forecast

    Drugmaker Merck & Co on Friday raised its full-year profit forecast after beating Wall Street estimates for quarterly profit as sales of blockbuster cancer drug Keytruda nearly doubled.

    Market Quotes by TradingView